At1g19930 Antibody

Shipped with Ice Packs
In Stock

Description

Understanding Antibody Development and Validation

Antibodies targeting specific proteins require rigorous validation to ensure specificity and functionality. Key considerations include:

  • Epitope Specificity: Antibodies must bind exclusively to their intended target. For example, studies on angiotensin II AT1 receptor antibodies revealed significant cross-reactivity and nonspecific binding in commercial products, leading to unreliable results in western blotting and immunohistochemistry .

  • Validation Methods: Antibody specificity is typically confirmed through knockout models, competitive binding assays, and epitope mapping. For instance, six commercially available AT1 receptor antibodies failed validation tests in wild-type versus knockout mice .

  • Application-Specific Performance: Antibodies may perform well in some assays (e.g., western blot) but fail in others (e.g., immunofluorescence) .

Relevant Case Studies in Antibody Research

While no data exists for At1g19930, insights can be drawn from analogous antibody research:

Table 1: Comparison of Antibody Validation Challenges

Antibody TargetKey FindingsSource
Angiotensin II AT1 ReceptorSix commercial antibodies showed nonspecific binding in knockout models.
GPCRs (AT1R/ETAR)Antibodies against these receptors activate signaling pathways and correlate with graft rejection in transplants.
Influenza NeuraminidaseBroadly reactive antibodies like 1G01 neutralize multiple viral strains via active-site binding.
Afucosylated AntibodiesEngineered antibodies (e.g., obinutuzumab) enhance ADCC for cancer therapy.

Hypothetical Framework for At1g19930 Antibody Development

If an antibody against At1g19930 were to be developed, the following steps would be critical:

  1. Target Identification: At1g19930 encodes a protein of unknown function in Arabidopsis. Homology modeling or structural studies would clarify its role.

  2. Epitope Design: A peptide sequence from the protein would be synthesized for immunization (e.g., residues 8–17 for extracellular domains) .

  3. Validation:

    • Knockout plant lines would confirm antibody specificity.

    • Cross-reactivity screening against related proteins (e.g., paralogs in Arabidopsis).

Lessons from Antibody Databases and Repositories

Databases like PLAbDab catalog antibody sequences and structures, emphasizing functional annotations and epitope diversity . For novel antibodies like At1g19930, submission to such repositories would enhance reproducibility and collaborative research.

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g19930 antibody; F6F9.32Putative F-box/kelch-repeat protein At1g19930 antibody
Target Names
At1g19930
Uniprot No.

Q&A

What is the At1g19930 protein and why is it significant in research?

At1g19930 is a putative F-box/kelch-repeat protein identified in Arabidopsis lyrata (and its homolog in Arabidopsis thaliana) . F-box proteins are critical components of SCF (Skp1-Cullin-F-box) ubiquitin ligase complexes that regulate protein degradation through the ubiquitin-proteasome pathway. The kelch-repeat motifs typically facilitate protein-protein interactions. This protein's significance lies in its potential role in plant development, stress responses, and cellular signaling pathways, making antibodies against it valuable tools for studying these processes .

How are At1g19930 antibodies typically generated for research purposes?

At1g19930 antibodies are typically generated through either polyclonal or monoclonal approaches. For polyclonal antibodies, a synthetic peptide or recombinant protein fragment corresponding to the At1g19930 sequence is used to immunize rabbits or other host animals. Multiple booster immunizations are performed over 2-3 months, followed by serum collection and affinity purification against the immunizing antigen. For monoclonal antibodies, a similar immunization protocol is followed, but splenic B cells from the immunized animal are subsequently fused with myeloma cells to generate hybridomas that produce single-specificity antibodies. Selection and screening processes identify clones producing antibodies with high specificity and affinity for the At1g19930 protein .

What are the recommended validation methods for At1g19930 antibodies?

Validation of At1g19930 antibodies should follow a multi-step approach:

  • Western blot analysis using both recombinant protein and plant tissue extracts to confirm expected molecular weight detection

  • Immunoprecipitation followed by mass spectrometry to verify antibody-antigen interaction

  • Immunohistochemistry/immunofluorescence to confirm expected subcellular localization

  • ELISA titration to determine sensitivity and working dilution ranges

  • Negative controls using knockout/knockdown plants or pre-immune serum

Always compare antibody reactivity between wild-type and At1g19930 mutant tissues to confirm specificity. Cross-reactivity testing with related F-box proteins helps establish selectivity profiles .

What are the common applications of At1g19930 antibodies in plant research?

At1g19930 antibodies serve multiple research applications:

ApplicationPurposeTypical Dilution Range
Western BlottingProtein expression quantification1:500 - 1:2000
ImmunoprecipitationProtein-protein interaction studies2-5 μg per 500 μg lysate
ImmunofluorescenceSubcellular localization1:100 - 1:500
Chromatin IPDNA-protein interaction analysis5-10 μg per reaction
ELISAQuantitative protein detection1:1000 - 1:5000

These applications enable researchers to investigate At1g19930's role in plant development, stress responses, and protein degradation pathways .

How should researchers address potential cross-reactivity with At1g19930 antibodies?

Cross-reactivity is a significant concern when working with antibodies against F-box/kelch-repeat proteins due to structural similarities among family members. Implement these strategies to address this issue:

  • Epitope selection optimization: Target unique regions of At1g19930 that diverge from related F-box proteins

  • Pre-absorption controls: Incubate antibodies with recombinant related proteins to remove cross-reactive antibodies

  • Knockout validation: Compare signal between wild-type and At1g19930 knockout plants

  • Mass spectrometry verification: Analyze immunoprecipitated proteins to identify potential cross-reactive targets

  • Parallel antibody validation: Use multiple antibodies targeting different epitopes of At1g19930

Additionally, perform regular Z-score normalization of signals when quantifying antibody binding across different experimental conditions, similar to approaches used in autoantibody research, to distinguish specific from non-specific binding .

What are the optimal fixation and extraction protocols for At1g19930 detection in plant tissues?

The detection of F-box/kelch-repeat proteins like At1g19930 requires careful consideration of fixation and extraction protocols:

For immunohistochemistry and immunofluorescence:

  • Paraformaldehyde (4%) fixation for 2-4 hours preserves protein structure while maintaining epitope accessibility

  • Avoid glutaraldehyde fixation which can mask epitopes through excessive cross-linking

  • For membrane-associated fractions, include a gentle permeabilization step with 0.1-0.3% Triton X-100

For protein extraction and western blotting:

  • Use extraction buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% NP-40 or Triton X-100, and 0.5% sodium deoxycholate

  • Include proteasome inhibitors (10μM MG132) and deubiquitinase inhibitors (5mM N-ethylmaleimide) to prevent degradation

  • Extract at 4°C to minimize degradation of ubiquitinated complexes

  • Consider native extraction conditions when studying protein-protein interactions .

How can researchers troubleshoot inconsistent At1g19930 antibody signals between experiments?

Inconsistent antibody signals can significantly impact research reproducibility. Address variability through systematic troubleshooting:

  • Antibody storage conditions: Store aliquoted antibody at -80°C and avoid repeated freeze-thaw cycles

  • Sample preparation standardization: Normalize protein extraction methods and quantification

  • Blocking optimization: Test alternative blocking agents (5% BSA vs. 5% milk) to reduce background

  • Signal normalization: Use multiple housekeeping controls suitable for your experimental conditions

  • Batch effects monitoring: Include internal reference samples across multiple experiments

  • Epitope accessibility verification: Test multiple antigen retrieval methods for fixed samples

Create a quality control checklist with predetermined acceptance criteria for each experiment. Statistical approaches using Z-score normalization similar to those employed in autoantibody research can help standardize signal interpretation across experiments .

What are the recommended controls for At1g19930 antibody experiments?

Robust experimental design requires comprehensive controls:

Control TypePurposeImplementation
Positive ControlVerify antibody functionalityRecombinant At1g19930 protein or overexpression lines
Negative ControlDetermine background/non-specific bindingAt1g19930 knockout/knockdown lines or pre-immune serum
Loading ControlNormalize protein loadingAnti-actin or anti-tubulin antibodies
Processing ControlVerify consistent sample preparationSpike-in standards or invariant proteins
Secondary Antibody ControlCheck secondary antibody specificityOmit primary antibody incubation
Isotype ControlAssess non-specific bindingSame isotype, irrelevant antibody

For experimental analysis, implement data normalization using Z-scores, particularly when comparing results across different experimental conditions or time points, similar to approaches used in autoantibody research .

How should researchers design time-course experiments to study At1g19930 protein dynamics?

Time-course experiments investigating At1g19930 dynamics require careful planning:

  • Temporal resolution planning: Determine appropriate time intervals based on expected protein turnover rates (typically 4-8 hours for many F-box proteins)

  • Synchronization protocols: Use controlled growth conditions or stimuli to synchronize biological responses

  • Sampling strategy: Implement both technical and biological replicates at each time point

  • Degradation inhibition: Include parallel samples treated with proteasome inhibitors to capture ubiquitination intermediates

  • Quantification approach: Use fluorescent secondary antibodies for wider linear detection range compared to chemiluminescence

  • Data analysis: Apply time-series statistical methods rather than simple pairwise comparisons

When analyzing time-course data, measure both absolute At1g19930 protein levels and relative changes normalized to baseline, similar to the approach used in tracking autoantibody responses over time in clinical studies .

What methodological considerations are important when using At1g19930 antibodies for protein-protein interaction studies?

Protein-protein interaction studies with At1g19930 require attention to several methodological factors:

  • Extraction conditions: Use gentle, non-denaturing buffers to preserve protein complexes (e.g., 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40)

  • Crosslinking considerations: For transient interactions, implement mild crosslinking (0.5-1% formaldehyde for 10 minutes)

  • Antibody orientation: Use both direct IP (antibody-to-bead) and antigen capture (lysate-to-antibody-to-bead) approaches

  • Binding kinetics: Allow sufficient incubation time (4-16 hours at 4°C) for complex formation

  • Washing stringency: Optimize salt and detergent concentrations to minimize non-specific binding without disrupting legitimate interactions

  • Elution strategy: Compare specific peptide elution versus boiling in SDS for different experimental endpoints

For confirmation, implement reciprocal co-immunoprecipitation using antibodies against suspected interaction partners and consider complementary techniques like proximity ligation assay or FRET to validate interactions in situ .

How should researchers quantify and interpret At1g19930 protein abundance changes in stress response studies?

Quantifying At1g19930 protein changes in stress response experiments requires sophisticated analysis approaches:

  • Normalization strategy: Use multiple reference proteins or total protein normalization (stain-free technology) rather than single housekeeping genes that may change under stress conditions

  • Statistical analysis: Apply repeated measures ANOVA with post-hoc tests for time-course experiments

  • Biological relevance threshold: Define meaningful fold-change thresholds based on system variability (typically >1.5-fold with p<0.05)

  • Concentration-response relationships: Analyze dose-dependent effects when applying graduated stress treatments

  • Correlation analysis: Compare At1g19930 protein dynamics with transcriptional changes and physiological responses

  • Multivariate pattern recognition: Use principal component analysis or clustering to identify patterns across multiple stress responses

When interpreting results, consider that F-box protein abundance often inversely correlates with activity due to auto-ubiquitination mechanisms. This approach mirrors techniques used in analyzing autoantibody responses in clinical studies, where both absolute levels and patterns of change provide meaningful insights .

What are the best practices for comparing results across different At1g19930 antibody lots or sources?

Antibody lot-to-lot variation can significantly impact experimental reproducibility. Implement these best practices:

  • Bridging study design: When transitioning to a new antibody lot, run parallel experiments with both old and new lots

  • Calibration curves: Develop standard curves using recombinant At1g19930 protein for each antibody lot

  • Epitope mapping: Verify that different antibody lots recognize the same epitope region

  • Sensitivity assessment: Determine detection limits for each antibody lot using dilution series

  • Cross-reactivity profiling: Test each lot against a panel of related F-box proteins

  • Documentation: Maintain detailed records of antibody source, lot number, and validation data

Consider creating an internal reference standard (pooled samples) that can be included in experiments with each antibody lot to enable direct comparison. Use Z-score normalization similar to approaches in autoantibody research to standardize results across different experimental batches .

How can researchers integrate At1g19930 protein data with transcriptomic and proteomic datasets?

Multi-omics integration provides comprehensive insights into At1g19930 function:

  • Temporal alignment: Adjust for time delays between transcriptional changes and protein abundance shifts (typically 4-12 hours in plants)

  • Data transformation: Convert raw values to comparable scales using Z-scores or percentile ranks

  • Correlation analysis: Calculate Pearson or Spearman correlations between At1g19930 protein levels and its potential targets

  • Network reconstruction: Use weighted gene correlation network analysis (WGCNA) to identify modules of co-regulated genes/proteins

  • Pathway enrichment: Analyze enriched biological pathways among correlated genes/proteins

  • Visualization strategies: Implement heatmaps, volcano plots, and network diagrams to effectively communicate multi-dimensional results

When interpreting integrated datasets, remember that F-box proteins often show complex relationships with their targets due to feedback mechanisms. This approach parallels methods used in autoantibody research for identifying patterns of immune responses that correlate with disease outcomes .

What emerging methodologies might enhance At1g19930 antibody research?

Several cutting-edge approaches show promise for advancing At1g19930 antibody research:

  • Proximity labeling: Using antibody-conjugated APEX2 or BioID systems to identify proteins in close proximity to At1g19930 in vivo

  • Super-resolution microscopy: Implementing STORM or PALM techniques with fluorophore-conjugated antibodies to visualize At1g19930 subcellular localization at nanometer resolution

  • Single-cell protein analysis: Adapting techniques like CyTOF or single-cell western blotting to examine At1g19930 expression heterogeneity within plant tissues

  • Intrabodies: Developing single-chain antibody fragments that can track At1g19930 in living cells

  • Nanobodies: Employing camelid-derived single-domain antibodies for improved penetration and reduced immunogenicity

  • Quantitative multiplexed immunohistochemistry: Using cyclic immunofluorescence or mass cytometry to simultaneously measure At1g19930 alongside dozens of other proteins

These advanced approaches will enable more detailed characterization of At1g19930's dynamic regulation and function in plant developmental and stress response pathways .

How might At1g19930 antibody research inform understanding of plant stress response mechanisms?

At1g19930 antibody research has significant potential to elucidate plant stress response mechanisms:

  • Stress-specific post-translational modifications: Using modification-specific antibodies to detect changes in At1g19930 phosphorylation, ubiquitination, or SUMOylation during different stress responses

  • Temporal dynamics: Tracking At1g19930 protein complex formation and dissociation during stress exposure and recovery

  • Spatial regulation: Examining changes in subcellular localization across different tissue types and developmental stages

  • Cross-talk analysis: Investigating At1g19930's role in integrating responses across multiple stress pathways

  • Evolutionary conservation: Comparing At1g19930 function across related plant species with varying stress tolerances

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.